Antidepressants and Suicide Risk: A Comprehensive Overview
Open accessThe DOI matches its Crossref record; 130 of the 133 references it cites were found in a registry or an index.
Abstract
The annual worldwide suicide rate currently averages approximately 13 per 100,000 individuals per year (0.013% per year), with higher average rates for men than for women in all but a few countries, very low rates in children, and relatively high rates in elderly men. Suicide rates vary markedly between countries, reflecting in part differences in case-identification and reporting procedures. Rates of attempted suicide in the general population average 20–30 times higher than rates of completed suicide, but are probably under-reported. Research on the relationship between pharmacotherapy and suicidal behavior was rare until a decade ago. Most ecological studies and large clinical studies have found that a general reduction in suicide rates is significantly correlated with higher rates of prescribing modern antidepressants. However, ecological, cohort and case-control studies and data from brief, randomized, controlled trials in patients with acute affective disorders have found increases, particularly in young patients and particularly for the risk of suicide attempts, as well as increases in suicidal ideation in young patients. whether antidepressants are associated with specific aspects of suicidality (e.g., higher rates of completed suicide, attempted suicide and suicidal ideation) in younger patients with major affective disorders remains a highly controversial question. In light of this gap this paper analyzes research on the relationship between suicidality and antidepressant treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The risk of suicide is increased by the presence of psychological factors such as depression, anxiety, emotional instability, and antisocial personality.15”
From Are smoking cessation treatments associated with suicidality risk? An overview (2016) · cites this paper as [15]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive Textbook of Psychiatry
Freedman, A. M., & Kaplan, H. I. (1967) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196712000-00052 · Cited by 3,799
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881
Kessler, R. C. (2005) · JAMA · doi:10.1001/jama.293.20.2487 · Cited by 1,073
Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16043-1 · Cited by 1,058
Suicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054
Reducing Suicide--A National Imperative
(2002) · PsycEXTRA Dataset · doi:10.1037/e719942007-001 · Cited by 902
Affective disorders and suicide risk: a reexamination
Bostwick, J. M., & Pankratz, V. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.12.1925 · Cited by 878 · cited 1×
“patients this risk ratio may be about three-times higher [91].”
BackgroundPIANTADOSI, S., BYAR, D. P., & GREEN, S. B. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114892 · Cited by 821
Research works printed but not linked: 5
- Tondo, 2006, Trends in suicide rates: An international perspective, Ital. J. Psychopathol, 12, 202
- Baldessarini, 2004, Morbidity from onset in first-episode bipolar I disorder patients: The International-300 study, Neuropsychopharmacology, 29, S88
- (1985). Electroconvulsive therapy. Natl. Inst. Health Consens. Dev. Conf. Consens. Statement, 5, 8.
- Brunton, L.L., Lazo, J.S., and Parker, K.L. (2005). Goodman and Gilman's Pharmacological Basis of Therapeutics, McGraw-Hill Press. [11th].
- Baldessarini, 2005, Antidepressants and Suicidal Behavior: Are We Hurting Or Helping?, Clin. Neuropsych., 2, 73
Cited by
Coupland, C., Hill, T., Morriss, R., Arthur, A., Moore, M., & Hippisley-Cox, J. (2015) · BMJ · doi:10.1136/bmj.h517 · Cited by 158
Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis
Bartoli, F., Riboldi, I., Crocamo, C., Brita, C. D., Clerici, M., & Carrà, G. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.03.010 · Cited by 121
The impact of Ayahuasca on suicidality: results from a randomized controlled trial
Zeifman, R. J., Palhano-Fontes, F., Hallak, J., Arcoverde, E., Maia-Oliveira, J. P., & Araujo, D. B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01325 · Cited by 87
“…(Bateman, 2012), (c) negative side-effects (e.g., increased suicidality with antidepressant use among adolescents; Vitiello and Ordóñez, 2016), (d) the need for ongoing administration (Kellner et al., 2005), and (e) high rates of non-responsiveness (Stone et al., 2009; Pompili et al., 2010).”
BackgroundForsman, J., Taipale, H. T., Masterman, T., Tiihonen, J., & Tanskanen, A. J. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-019-02707-z · Cited by 52
Zajac, I. T., Rice, S., Proeve, M. J., Kealy, D., Oliffe, J. L., & Ogrodniczuk, J. S. (2020) · Journal of Mental Health · doi:10.1080/09638237.2020.1755026 · Cited by 39
Nyer, M., Gerbarg, P., Silveri, M., Johnston, J. M., Scott, T., Nauphal, M., Owen, L., Nielsen, G. H., Mischoulon, D., Brown, R. P., et al. (2018) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2018.02.006 · Cited by 28
Gao, Y., Wei, E. K., Arron, S. T., Linos, E., Margolis, D. J., & Mansh, M. D. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.06.004 · Cited by 26
Selective serotonin re-uptake inhibitors for premature ejaculation in adult men
Sathianathen, N. J., Hwang, E. C., Mian, R., Bodie, J., Soubra, A., Lyon, J. A., Sultan, S., & Dahm, P. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012799.pub2 · Cited by 25
Gniazdowska, E., Korytowska, N., Kłudka, G., & Giebułtowicz, J. (2020) · Pharmaceuticals · doi:10.3390/ph13120458 · Cited by 21
New investigational agents for the treatment of major depressive disorder
Pochwat, B., Krupa, A. J., Siwek, M., & Szewczyk, B. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2113376 · Cited by 23
Pan, Y., Gorenflo, M. P., Davis, P. B., Kaelber, D. C., Luca, S. M. D., & Xu, R. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03033-4 · Cited by 25
Nguyen, N. P. K., Kwon, J.-H., Kim, M. K., Tran, K. N., Nguyen, L. T. H., & Yang, I. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1359427 · Cited by 23
Antidepressants and Adolescent Brain Development
Karanges, E. A., & McGregor, I. S. (2011) · Future Neurology · doi:10.2217/fnl.11.51 · Cited by 18
Jamieson, C., Canuso, C. M., Ionescu, D. F., Lane, R., Qiu, X., Rozjabek, H., Molero, P., & Fu, D. (2023) · Quality of Life Research · doi:10.1007/s11136-023-03451-9 · Cited by 18
Suicidal behaviours in men: Determinants and prevention in Australia
Kõlves, K., Kumpula, E., & Leo, D. D. (2013) · Griffith Research Online · Cited by 13
Yager, J., & Feinstein, R. E. (2017) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000701 · Cited by 10
Association of Selected Area-Level Indicators With Suicide Mortality in Slovenian Municipalities
Roškar, S., Sedlar, N., Furman, L., Roškar, M., & Podlešek, A. (2020) · Crisis · doi:10.1027/0227-5910/a000742 · Cited by 9
Psychological and neuropsychological prevention of suicide risk factors in college students
Ibáñez, N. N. C. (2016) · psicogente · doi:10.17081/psico.19.36.1302 · Cited by 13
Depression, suicide, and violence
Okpaku, S. O. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139136341.041 · Cited by 8
Are smoking cessation treatments associated with suicidality risk? An overview
Penberthy, J. K., Penberthy, J. M., Harris, M. R., Nanda, S., Ahn, J., Martinez, C. P., Osika, A. O., Slepian, Z. A., Forsyth, J. C., Starr, J. A., et al. (2016) · Substance Abuse: Research and Treatment · doi:10.4137/sart.s33389 · Cited by 6
Wahdan, A., & Helal, N. E. (2021) · Ain Shams Journal of Forensic Medicine and Clinical Toxicology · doi:10.21608/ajfm.2021.185478 · Cited by 9
Cremaschi, L., Grancini, B. M., Carlo, V. D., Pozzoli, S. M., Altamura, A. C., & Dell’Osso, B. M. (2018) · Aging Clinical and Experimental Research · doi:10.1007/s40520-018-0966-1 · Cited by 6
Li, J., Ma, L., Sun, H., Li, M., Cao, Y., Peng, Y., & Xu, J. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01920-x · Cited by 5
“Therefore, patients taking these medications are at an increased risk for suicidal thoughts and depressive symptoms before reaching maximum anti - depressant efficacy, which typically takes several weeks [ 10, 11 ].”
Pharmacological Strategies for Suicide Prevention Based on the Social Pain Model: A Scoping Review
Rajkumar, R. P. (2022) · Psych · doi:10.3390/psych4030038 · Cited by 5
Narindrarangkura, P., Alafaireet, P. E., Khan, U., & Kim, M. S. (2023) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174231162477 · Cited by 4
Jakienė, V., Raškauskienė, N., Naginienė, R., & Mickuvienė, N. (2024) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2024.100799 · Cited by 4
Drugs for Neuropsychiatric Disorders
Pryor, K. O., & Storer, K. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-48110-6.00012-0 · Cited by 5
Szewczyk, M., Punda, P., Janikowska, K., & Makowiec, S. (2019) · Journal of Chemical Sciences · doi:10.1007/s12039-019-1621-x · Cited by 4
Miranda, O., Qi, X., Brannock, D., Whitworth, R., Kosten, T. R., Ryan, N. D., Haas, G. L., Kirisci, L., & Wang, L. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1526488 · Cited by 4
Antidepressants and Suicidality—Controversies and Possible Mechanisms
Witt-Doerring, J., & Mathew, S. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00027-5 · Cited by 3
McGarry, A. J., Auinger, P., Kieburtz, K. D., Bredlau, A., Hersch, S. M., & Rosas, H. D. (2022) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000001161 · Cited by 4
Assessing suicide risk in chronic pain management: a narrative review across drug classes
Brezić, N., Gligorevic, S., Candido, K. D., & Knežević, N. N. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2391999 · Cited by 2
Nutraceuticals in the Treatment of Major Depressive Disorder
Davis, A., Pence, J., & Bloomer, R. J. (2025) · Nutraceuticals · doi:10.3390/nutraceuticals5030027 · Cited by 3
Kamishikiryo, T., Itai, E., Mitsuyama, Y., Masuda, Y., yamamoto, O., Tamura, T., Jitsuiki, H., Mantani, A., yokota, N., & Okada, G. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03796-4 · Cited by 2
The Need for Non-profit Psychiatric Drug Discovery and Development
Ghaemi, S. N. (2022) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001607 · Cited by 2
Pan, Y., Yeh, L., & Kuo, K. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104091 · Cited by 4
Opioid Prescribing in Orthopaedic Surgery: An Evolving Paradigm
Kidd, V. D. (2018) · JBJS Journal of Orthopaedics for Physician Assistants · doi:10.2106/jbjs.jopa.17.00033 · Cited by 2
Drugs for Neuropsychiatric Disorders
Pryor, K. O., & Storer, K. P. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1679-5.00011-9 · Cited by 4
Campos, A. I., Byrne, E. M., Iorfino, F., Fabbri, C., Hickie, I. B., Lewis, C. M., Wray, N. R., Medland, S. E., Rentería, M. E., & Martin, N. G. (2022) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32913 · Cited by 3
Suicide and psychiatric disorders
Berardelli, I., Rogante, E., Lamis, D. A., & Pompili, M. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780198843405.003.0018 · Cited by 2
Self-citationSeifert, J., Bleich, S., & Seifert, R. (2023) · Springer eBooks · doi:10.1007/978-3-662-68371-2_22 · Cited by 2
Invisible Victims and the Case for OTC SSRIs
Appel, J. M. (2024) · Cambridge Quarterly of Healthcare Ethics · doi:10.1017/s096318012400032x · Cited by 1
Another Step Toward Clarifying the Benefits and Burdens of Selective Serotonin Reuptake Inhibitors
Wulsin, L. R. (2019) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000735
Obsessive-Compulsive and Related Disorders in Transitional-Age Youth
Okereke, N. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-62113-1_9
Suicidalitet relatert til SSRI ved behandling av depresjon hos barn og unge – en litteraturstudie
Leines, H. F., & Høye, A. (2021) · Suicidologi/Nytt i suicidologi · doi:10.5617/suicidologi.8918
Antidepressant Medication and Psychotherapy: Why It Matters
Chiesa, M. (2024) · British Journal of Psychotherapy · doi:10.1111/bjp.12938
Gracia, H. A., Giménez‐Palomo, A., Olivier, L., Ochandiano, I., de Juan, O., Fernández‐Plaza, T., Salmerón, S., Colomer, L., Vieta, E., & Pacchiarotti, I. (2025) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.70049
Samant, R. R., Bhatia, D., Meng, Q., Chen, Y., Hageman, L., Francisco, L., Palmer, S., Choe, M., Balas, N. A., Bosworth, A., et al. (2026) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2026.04.051
Armstrong, S. B., Levin, A. W., Sepeda, N. D., Shaub, H., Hunter, T., Douglas, A., Lancelotta, R., & Davis, A. K. (2026) · Communications Medicine · doi:10.1038/s43856-026-01767-4 · Cited by 1
Jiang, C., Huang, R., Eldeeb, S. M., Wang, H., Zeng, Z. C., Beck, K. B., Ryan, N. D., Mazefsky, C. A., & Wang, L. (2026) · medRxiv · doi:10.64898/2026.10.21.26366126
Metadata
- Authors
- Pompili, M., Serafini, G., Innamorati, M., Ambrosi, E., Giordano, G., Girardi, P., Tatarelli, R., & Lester, D.
- Affiliations
- Harvard University (US)
- Azienda Ospedaliera Sant'Andrea (IT)
- Stockton University (US)
- Corresponding author
- Pompili, Maurizio
- ORCID
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2010-08-30
- Volume
- 3
- Issue
- 9
- Pages
- 2861-2883
- ISSN
- 1424-8247 (ISSN-L)
- PMC
- PMC4034101
- OpenAlex
- W2113295845
- Cited by
- 53
- References
- 133
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 9 · 2023: 4 · 2022: 5 · 2021: 4 · 2020: 3 · 2019: 5 · 2018: 4 · 2017: 3 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 2
- FWCI
- 0.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pharmaceuticals (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- antidepressants, suicide risk, suicidal ideation, suicide attempts, suicide mortality, major depressive disorder, young patients, drug therapy safety, antidepressant prescribing, suicide rates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.